We are live on ! Find out more
ALT icon

Altimmune

120 hedge funds and large institutions have $125M invested in Altimmune in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more call options, than puts

Call options by funds: $2.04M | Put options by funds: $997K

19% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 32

9% less funds holding

Funds holding: 132120 (-12)

16.53% less ownership

Funds ownership: 88.08%71.55% (-17%)

26% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 42

39% less capital invested

Capital invested by funds: $205M → $125M (-$80.8M)

Holders
120
Holders Change
-12
Holders Change %
-9.09%
% of All Funds
1.88%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
31
Increased
38
Reduced
32
Closed
42
Calls
$2.04M
Puts
$997K
Net Calls
+$1.04M
Net Calls Change
-$10.6M
Name Holding Trade Value Shares
Change
Change in
Stake
6CM
151
683 Capital Management
New York
-$59.1K -14,000 Closed
Point72 Asset Management
152
Point72 Asset Management
Connecticut
-$59K -13,987 Closed
BHCM
153
Boulder Hill Capital Management
New York
-$49.8K -11,800 Closed
VEA
154
Virtus ETF Advisers
New York
-$39.6K -9,389 Closed
PI
155
PEAK6 Investments
Illinois
-$11K -2,600 Closed
Canada Life
156
Canada Life
Manitoba, Canada
-$10K -2,465 Closed
QT
157
Quantbot Technologies
New York
-$8.77K -2,077 Closed
US Bancorp
158
US Bancorp
Minnesota
-$2.11K -500 Closed
TWA
159
TCI Wealth Advisors
Arizona
-$701 -166 Closed
Capstone Investment Advisors
160
Capstone Investment Advisors
New York
-$363 -86 Closed

ALT Hedge Fund Activity: Q2 2023 in Review

120 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q2 2023, worth a combined $125M — down 39% from $205M a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of ALT and 31 opened new positions — a net loss of 11 holders — while 32 trimmed existing stakes and 38 added.

The largest buyer was BlackRock, adding an estimated $10.2M. The largest seller was State Street, cutting an estimated $18.7M.

  • 120 institutional investors held Altimmune (ALT) as of Q2 2023, down from 132 in Q1 2023.
  • Funds reported $125M of Altimmune stock for Q2 2023, down 39% quarter-over-quarter.
  • 31 funds opened new Altimmune positions in Q2 2023 and 42 closed out, a net change of -11 holders.
  • The largest Altimmune buyer in Q2 2023 was BlackRock, an estimated $10.2M added.
  • The largest Altimmune seller in Q2 2023 was State Street, an estimated $18.7M sold.

Based on aggregated 13F filings for Q2 2023.